TLR2 and neoplasm: To explore the inflammatory stimuli from CTCs that stimulate G-CSF and IL-6 expression, we focused on the tumor cell-derived TLR2 and TLR4 (TLR2/4) ligands, since IL-37 could suppress TLR4 ligand-induced inflammatory response [22, 38].